Loading...
Early treatment uptake and cost burden of hepatitis C therapies among newly diagnosed hepatitis C patients with a particular focus on HIV coinfection
BACKGROUND: Despite the high efficacy and safety associated with direct-acting antivirals (DAAs), access to HCV treatment has been frequently restricted because of the high DAA drug costs. OBJECTIVES: To (1) compare HCV treatment initiation rates between HCV monoinfected and HCV/HIV coinfected patie...
Na minha lista:
| Udgivet i: | Dig Dis Sci |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7358122/ https://ncbi.nlm.nih.gov/pubmed/31938995 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-019-06037-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|